# Viral Kinetics in HCV Clearance in Subjects With Hemophilia

> **NCT01704521** · PHASE1 · COMPLETED · sponsor: **Kenneth Sherman** · enrollment: 5 (actual)

## Conditions studied

- Chronic Hepatitis C
- Hemophilia

## Interventions

- **DRUG:** PegInterferon
- **DRUG:** Ribavirin
- **DRUG:** Telaprevir

## Key facts

- **NCT ID:** NCT01704521
- **Lead sponsor:** Kenneth Sherman
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704521, "Viral Kinetics in HCV Clearance in Subjects With Hemophilia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01704521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*